C-CBL mutations and uses thereof
US11390922B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 25, 2018 |
| Grant date | Jul 19, 2022 |
| Priority date | — |
| Expiry date | Dec 19, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates generally to the fields of molecular biology and growth factor regulation. The invention concerns methods and compositions useful for diagnosing and treating human lung cancer associated with mutated c-CBL.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.